Porcine factor VIII: Pharmacoeconomics of inhibitor therapy

Haemophilia

Volumn 8, Issue SUPPL. 1, 2002, Pages 13-16

  Ewenstein, B M ^a,b   Avorn, J ^a   Putnam, K G ^a   Bohn, R L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Clinical decision making; Haemophilia; Inhibitors; Pharmacoeconomics

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; AUTOANTIBODY; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; PROTHROMBIN COMPLEX CONCENTRATES;

ADULT; ARTICLE; BLEEDING; CASE REPORT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG FORMULATION; FEMALE; FOLLOW UP; HEALTH CARE COST; HEMOPHILIA; HUMAN; MEDICAL INFORMATION; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROCESS MODEL; SENSITIVITY ANALYSIS; ALGORITHM; ANIMAL; AUTOIMMUNE DISEASE; BLOOD; COMPARATIVE STUDY; DRUG COST; ECONOMICS; HEMOPHILIA A; IMMUNOLOGY; PHARMACOECONOMICS; PHARMACOKINETICS; SWINE;

ALGORITHMS; ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLOOD COAGULATION FACTORS; COST-BENEFIT ANALYSIS; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; FACTOR VIII; HEMOPHILIA A; HUMANS; SWINE; THERAPEUTIC EQUIVALENCY;

EID: 0036210860     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2002.00135.x     Document Type: Article

References (7)

1. Acquired haemophilia and its management
2. Acquired haemophilia and its treatment
3. Acquired haemophilia
4. A survey of 215 non-hemophilic patients with inhibitors to factor VIII
5. Use of porcine factor VIII in the treatment of patients with acquired hemophilia
6. Inactivation of factor VIII coagulant activity by two different types of human antibodies
7. Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20 years